SKF to publish Q3 report on 30 October

2024-10-17 SKF HaiPress

GOTHENBURG,Sweden,Oct. 16,2024 -- SKF will publish its Q3 results for 2024 on 30 October at approximately 07:00 (CET).

Investors,analysts and media are invited to join a webcast,which will be held in English,at 08:00 (CET).

To join the webcast,please login at least 10 minutes before the start using the below link or phone numbers:


Link to web event: https://www.investis-live.com/skf/6703fe36b2cedb000e390899/aherus


Sweden: +46 8 5051 0031


UK / International: +44 207 107 0613

All information regarding the results will be made available on the Group's IR website: https://investors.skf.com/en/quarterly-reports

Media:To book interviews with Rickard Gustafson,President and CEO,or Niclas Rosenlew,CFO,after the webcast,please contact Carl Bjernstam on carl.bjernstam@skf.com.

Aktiebolaget SKF


(publ)

For further information,please contact:


PRESS: Carl Bjernstam,Head of Media Relations


tel: 46 31-337 2517;mobile: 46 722-201 893;e-mail: carl.bjernstam@skf.com


INVESTOR RELATIONS: Sophie Arnius,Head of Investor Relations


tel: 46 31-337 8072; mobile: 46 705-908 072; e-mail: sophie.arnius@skf.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/skf/r/skf-to-publish-q3-report-on-30-october,c4051570

The following files are available for download:

https://mb.cision.com/Main/637/4051570/3055428.pdf

20241016 SKF to publish Q3 report on 30 October

https://news.cision.com/skf/i/skf-ceramic-bearing,c3342539

SKF Ceramic Bearing

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map